# EDGAR Filing Document

**Accession Number:** 0001817229
**File Stem:** 0001193125-26-204013
**Filing Date:** 2026-5
**Character Count:** 2281
**Document Hash:** 7955ade670477a6b15aaff0c14e10c82
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-204013.hdr.sgml**: 20260604

**ACCESSION NUMBER**: 0001193125-26-204013

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260504

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Vor Biopharma Inc.
- **CENTRAL INDEX KEY:** 0001817229
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 811591163
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 500 BOYLSTON STREET
- **STREET 2:** SUITE 1350
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 617-655-6580

**MAIL ADDRESS:**
- **STREET 1:** 500 BOYLSTON STREET
- **STREET 2:** SUITE 1350
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

**Vor Biopharma Inc.** 

500 Boylston Street, Suite 1350

Boston, MA 02116

May 4, 2026

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Tyler Howes

---

| | |
|:---|:---|
| **RE:** | **Vor Biopharma Inc.**  |

---

**Registration Statement on Form S-3 (File No. 333- 295346)** 

**Request for Acceleration of Effective Date** 

**Requested Date: May 6, 2026**

**Requested Time: 4:00 p.m. Eastern Time**

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the "***Registrant***") hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333- 295346) (the "***Registration Statement***") to become effective on May 6, 2026, at 4:00 p.m. Eastern Time, or as soon thereafter as is practicable.

Once the Registration Statement has been declared effective, please orally confirm that event with Madison Jones of Cooley LLP, counsel to the Registrant, at (202) 728-7087, or in her absence, David Brinton at (202) 776-2989.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **Vor Biopharma Inc.** | **Vor Biopharma Inc.** |
| By: | /s/ Adi Osovsky |
| Name: | Adi Osovsky |
| Title: | General Counsel and Secretary |

---